In this episode of "The Top Line," Zoey Becker talks with Dr. Andrew Norden, Chief Medical Officer at OncoHealth, about the ongoing chemotherapy shortage sweeping the nation and what oncologists and health insurance companies can do to best support patients amidst these supply chain issues. 

We also cover the a single-injection treatment for sickle cell disease, battery-powered gene therapy, and the rest of the week's headlines. 

To learn more about the topics in this episode:
National cancer group reports widespread chemo shortages, calls on government and industry to help resolve them
FDA to allow temporary overseas production to shore up supplies of chemo drug
FDA can't solve drug shortages on its own, agency's oncology chief says
FDA links 4 deaths to recalled Abiomed Impella pumps after TAVR collisions
Quest launches blood test for Alzheimer's disease aimed at general consumers
One injection to cure sickle cell? Researchers give it a shot with new mRNA gene therapy
With 3 AA batteries and 2 acupuncture needles, a device controls gene expression in live mice


"The Top Line" and "Podnosis" are produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.

In this episode of "The Top Line," Zoey Becker talks with Dr. Andrew Norden, Chief Medical Officer at OncoHealth, about the ongoing chemotherapy shortage sweeping the nation and what oncologists and health insurance companies can do to best support patients amidst these supply chain issues. 
We also cover the a single-injection treatment for sickle cell disease, battery-powered gene therapy, and the rest of the week's headlines. 
To learn more about the topics in this episode:
<ul>
<li><a href="https://www.fiercepharma.com/pharma/national-cancer-center-network-reports-major-chemotherapy-shortages-calls-government">National cancer group reports widespread chemo shortages, calls on government and industry to help resolve them</a></li>
<li><a href="https://www.fiercepharma.com/pharma/national-cancer-center-network-reports-major-chemotherapy-shortages-calls-government"></a><a href="https://www.fiercepharma.com/manufacturing/fda-allow-temporary-overseas-production-shore-supplies-chemo-drug">FDA to allow temporary overseas production to shore up supplies of chemo drug</a></li>
<li><a href="https://www.fiercepharma.com/manufacturing/fda-allow-temporary-overseas-production-shore-supplies-chemo-drug"></a><a href="https://www.fiercepharma.com/manufacturing/failure-market-results-persisting-shortages-fda-oncology-director-says-report#:~:text=Ultimately%2C%20the%20FDA%20can't,the%20market%2C%E2%80%9D%20Pazdur%20emphasized.">FDA can't solve drug shortages on its own, agency's oncology chief says</a></li>
<li><a href="https://www.fiercepharma.com/manufacturing/failure-market-results-persisting-shortages-fda-oncology-director-says-report#:~:text=Ultimately%2C%20the%20FDA%20can't,the%20market%2C%E2%80%9D%20Pazdur%20emphasized."></a><a href="https://www.fiercebiotech.com/medtech/fda-links-four-deaths-recalled-abiomed-impella-pumps-after-tavr-collisions">FDA links 4 deaths to recalled Abiomed Impella pumps after TAVR collisions</a></li>
<li><a href="https://www.fiercebiotech.com/medtech/fda-links-four-deaths-recalled-abiomed-impella-pumps-after-tavr-collisions"></a><a href="https://www.fiercebiotech.com/medtech/quest-launches-blood-test-alzheimers-disease-aimed-general-consumers">Quest launches blood test for Alzheimer's disease aimed at general consumers</a></li>
<li><a href="https://www.fiercebiotech.com/medtech/quest-launches-blood-test-alzheimers-disease-aimed-general-consumers"></a><a href="https://www.fiercebiotech.com/research/one-injection-cure-sickle-cell-disease-new-mrna-gene-therapy-researchers-are-giving-it">One injection to cure sickle cell? Researchers give it a shot with new mRNA gene therapy</a></li>
<li><a href="https://www.fiercebiotech.com/research/one-injection-cure-sickle-cell-disease-new-mrna-gene-therapy-researchers-are-giving-it"></a><a href="https://www.fiercebiotech.com/research/three-aa-batteries-and-two-acupuncture-needles-device-controls-gene-expression-live-mice">With 3 AA batteries and 2 acupuncture needles, a device controls gene expression in live mice</a><a href="https://www.fiercebiotech.com/research/one-injection-cure-sickle-cell-disease-new-mrna-gene-therapy-researchers-are-giving-it"></a><a href="https://www.fiercebiotech.com/medtech/quest-launches-blood-test-alzheimers-disease-aimed-general-consumers"></a><a href="https://www.fiercebiotech.com/medtech/fda-links-four-deaths-recalled-abiomed-impella-pumps-after-tavr-collisions"></a><a href="https://www.fiercepharma.com/manufacturing/failure-market-results-persisting-shortages-fda-oncology-director-says-report#:~:text=Ultimately%2C%20the%20FDA%20can't,the%20market%2C%E2%80%9D%20Pazdur%20emphasized."></a><a href="https://www.fiercepharma.com/manufacturing/fda-allow-temporary-overseas-production-shore-supplies-chemo-drug"></a><a href="https://www.fiercepharma.com/pharma/national-cancer-center-network-reports-major-chemotherapy-shortages-calls-government"></a><a href="https://www.fiercepharma.com/manufacturing/fda-allow-temporary-overseas-production-shore-supplies-chemo-drug"></a><a href="https://www.fiercepharma.com/manufacturing/failure-market-results-persisting-shortages-fda-oncology-director-says-report#:~:text=Ultimately%2C%20the%20FDA%20can't,the%20market%2C%E2%80%9D%20Pazdur%20emphasized."></a><a href="https://www.fiercebiotech.com/medtech/fda-links-four-deaths-recalled-abiomed-impella-pumps-after-tavr-collisions"></a><a href="https://www.fiercebiotech.com/medtech/quest-launches-blood-test-alzheimers-disease-aimed-general-consumers"></a><a href="https://www.fiercebiotech.com/research/one-injection-cure-sickle-cell-disease-new-mrna-gene-therapy-researchers-are-giving-it"></a><a href="https://www.fiercebiotech.com/research/three-aa-batteries-and-two-acupuncture-needles-device-controls-gene-expression-live-mice"> </a></li>
</ul>
"The Top Line" and "Podnosis" are produced by senior podcast producer Teresa Carey. The stories are by all our “Fierce” journalists. Like and subscribe wherever you listen to your podcasts.

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning. 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.&nbsp;

The Top Line

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We’ll analyze the week’s biggest business news—from mergers and marketing to drug R&D and device development. Available every Friday morning.

 

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech and Fierce Pharma recount the latest industry trends and why they matter. We&rsquo;ll analyze the week&rsquo;s biggest business news&mdash;from mergers and marketing to drug R&amp;D and device development. Available every Friday morning.
&nbsp;

Advertisement